Skip to main content

What the FDA labels say about taking them together

Burosumab and doxercalciferol

Burosumab's FDA label of April 22, 2026 names doxercalciferol in its contraindications section; the doxercalciferol label PlainMeds reads does not name burosumab. The burosumab label: “CONTRAINDICATIONS CRYSVITA is contraindicated: In concomitant use with oral phosphate and/or active vitamin D analogs due to the risk of hyperphosphatemia.”

Check it at the source: the burosumab FDA label on DailyMed (effective April 22, 2026); the doxercalciferol FDA label on DailyMed (effective October 23, 2025, Eugia US LLC).

What does the burosumab label say about doxercalciferol?

Burosumab label, contraindications

CONTRAINDICATIONS CRYSVITA is contraindicated: In concomitant use with oral phosphate and/or active vitamin D analogs (e.g. calcitriol, paricalcitol, doxercalciferol, calcifediol) due to the risk of hyperphosphatemia [see Warnings and Precautions (5.2) and Drug Interactions (7.1) ].

Source: FDA drug label (CRYSVITA), Kyowa Kirin, Inc., effective April 22, 2026 (SPL set 102f96a0-6e3a-4fc1-b204-34d604683af6), via openFDA; the full label on DailyMed

What does the doxercalciferol label say about burosumab?

Doxercalciferol's label (effective October 23, 2025) does not name burosumab in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Doxercalciferol), Eugia US LLC, effective October 23, 2025 (SPL set 3376536b-043d-478a-b129-7ce11ec94e3e), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Burosumab generic labelers
8Doxercalciferol generic labelers
BurosumabDoxercalciferol
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?